Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitors
Crossref DOI link: https://doi.org/10.1186/s12916-015-0454-9
Published Online: 2015-09-09
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Marques, Maud
Beauchamp, Marie-Claude
Fleury, Hubert
Laskov, Ido
Qiang, Sun
Pelmus, Manuela
Provencher, Diane
Mes-Masson, Anne-Marie
Gotlieb, Walter H.
Witcher, Michael
License valid from 2015-09-09